![Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/figures/mm7050e2-F.gif?_=40233)
Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR
Primary vaccination series and booster neutralizing ability and percent... | Download Scientific Diagram
![Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_726628_16644569677053962.jpg)
Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance
Centers for Disease Control and Prevention en LinkedIn: CDC recommends that everyone ages 5 years and older get an updated… | 26 comentarios
![Ministry of Health on Twitter: "🗓️ From 1 Jun 2022, recovered persons aged 12 and above who have completed their primary vaccination, will need to receive their COVID-19 booster dose within 9 Ministry of Health on Twitter: "🗓️ From 1 Jun 2022, recovered persons aged 12 and above who have completed their primary vaccination, will need to receive their COVID-19 booster dose within 9](https://pbs.twimg.com/media/FT1hbCRacAEEmFN.jpg:large)
Ministry of Health on Twitter: "🗓️ From 1 Jun 2022, recovered persons aged 12 and above who have completed their primary vaccination, will need to receive their COVID-19 booster dose within 9
![Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/21aefd8d-1880-42db-8338-92a386a5842f/gr1.jpg)
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases
![mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_726471_16643597014225567.jpg)